Pharmaceutical
| Sun 02 Feb 2025
Alexandria, Feb. 3 -- Biomarin Pharmaceutical has submitted a patent application for cnp therapy. Jeha George, Bauer Christopher, Covarrubias Sergio, Shanghavi Devanshi, Tseng Yu-Shan, Day Jonathan and Fisheleva Elena developed the invention.
The patent application number is US202218717353 20221207. The patent publication num..